
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies
|
|||||
![]() A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies ![]() Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal ![]() Four companies from the computer technology and genomics industries are starting a coalition to advance DNA as a data storage medium. . . . → Read More: Tech, Genomics Companies Form DNA Storage Alliance ![]() A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round. . . . → Read More: Gene-Editing Enzyme Start-Up Gains $65M ![]() Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk. . . . → Read More: Oral Drug Delivery Company Acquired in $1.8B Deal ![]() Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases. . . . → Read More: Crispr Therapy Shown to Help Blood Disorder Patients ![]() First results from an early-stage clinical trial show an RNA-based vaccine to prevent Covid-19 infections is safe and produces a complex immune response. . . . → Read More: Trial Shows Covid-19 Vaccine Safety, Immune Response ![]() Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide. . . . → Read More: 200M Covid-19 Vaccine Doses Donated to Int’l Effort ![]() Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components. . . . → Read More: Novartis Gains Synthetic Protein Therapies for Covid-19 ![]() Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders. . . . → Read More: Bayer Gains Gene Therapy Biotech in $4B Deal |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |